Press Releases MIRA Pharmaceuticals’ Lead Drug Candidate Ketamir-2 First Manuscript Accepted for Publication in the Peer-Reviewed Journal Frontiers in Pharmacology ...

MIRA Pharmaceuticals’ Lead Drug Candidate Ketamir-2 First Manuscript Accepted for Publication in the Peer-Reviewed Journal Frontiers in Pharmacology ...

MIRA Pharmaceuticals' Lead Drug Candidate Ketamir-2 First Manuscript Accepted for Publication in the Peer-Reviewed Journal Frontiers in Pharmacology Provided by ACCESS Newswire Jun 18, 2025, 5:30: ...

“This peer-reviewed publication provides clear validation of the differentiated pharmacological profile of Ketamir-2,” added Dr. Itzchak Angel, Chief Scientific Advisor.

RFK Jr. says he may bar scientists from publishing in top medical journals Health Secretary Robert F. Kennedy Jr. took aim at reputed journals such as the Lancet and said his agency will create ...

Last night, at Peer Gynt, the stage at the Stifel was chock-a-block with the full St. Louis Symphony Orchestra and the SLSO Chorus—plus ten actors/singers to play the roles in Ibsen’s ...

The US Department of Health and Human Services on Thursday released a 400-page review of treatment for gender dysphoria in children but did not disclose who authored or reviewed the report.